AJU IB Investment Co., Ltd.
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed April 8, 2025), AJU IB Investment Co., Ltd. reported 8 stock positions worth $84.0 million. Its top holding was Arcellx (ACLX) at 81.8% of the portfolio, followed by Kymera Therapeutics (KYMR, 14.9%) and Seer (SEER, 1.6%). Its holdings were unchanged from Q4 2024.
- Most Recent 13F
- Q2 2026
- Location
- Seoul, M5
- CIK
- 0001710065
- Portfolio Value
- $84.0M (Q1 2025)
- SEC Filing
- 0001140361-25-012676 ↗ filed Apr 8, 2025
Holdings Value
Holdings 8 stocks · $84.0M
| ACLX Arcellx Inc. | 81.77% | 1,047,557 | $68.7M | No change |
| KYMR Kymera Therapeutics Inc. | 14.88% | 457,059 | $12.5M | No change |
| SEER Seer Inc. | 1.64% | 816,375 | $1.4M | No change |
| RLYB Rallybio Corp. | 0.59% | 754,678 | $494K | No change |
| XLO Xilio Therapeutics Inc. | 0.58% | 667,742 | $484K | No change |
| CARM Carisma Therapeutics Inc. | 0.27% | 718,332 | $223K | No change |
| RAPT THERAPEUTICS INC | 0.14% | 99,503 | $121K | No change |
| STRO Sutro Biopharma Inc. Com SHS | 0.14% | 175,000 | $114K | No change |
Portfolio Sells Q4 2024 → Q1 2025
| None this quarter. | |||
Portfolio Buys Q4 2024 → Q1 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 0 | $0 | |
| Q1 2026 | 6 | $30.5M | ACLX, KYMR, SEER, RLYB, STRO |
| Q4 2025 | 7 | $22.8M | ACLX, RLYB, KYMR, SEER, XLO |
| Q3 2025 | 7 | $115.1M | ACLX, KYMR, SEER, XLO, RLYB |
| Q2 2025 | 8 | $91.9M | ACLX, KYMR, SEER, XLO, CARM |
| Q1 2025 | 8 | $84.0M | ACLX, KYMR, SEER, RLYB, XLO |
| Q4 2024 | 8 | $102.8M | ACLX, KYMR, SEER, RLYB, XLO |